400 related articles for article (PubMed ID: 10526270)
1. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
2. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Binelli G; Gelatti U; Portera G; Albertini A; Fasola M; Chiesa R; Nardi G
Hepatology; 1999 Jul; 30(1):294-9. PubMed ID: 10385670
[TBL] [Abstract][Full Text] [Related]
3. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
4. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
5. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
[TBL] [Abstract][Full Text] [Related]
6. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis.
Kheradpezhouh M; Taremi M; Gachkar L; Aghabozorgi S; Khoshbaten M
J Microbiol Immunol Infect; 2007 Apr; 40(2):106-11. PubMed ID: 17446957
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of transfusion transmitted virus infection and its effect on renal graft survival in renal transplant recipients.
Usta M; Dilek K; Ersoy A; Ozdemir B; Mistik R; Vuruskan H; Gullulu M; Yavuz M; Oktay B; Yurtkuran M
Scand J Urol Nephrol; 2002; 36(6):473-7. PubMed ID: 12623514
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
9. TT virus infection during chronic hepatitis C.
Trimoulet P; de Lédinghen V; Ekouevi D; Bernard PH; Merel P; Chêne G; Couzigou P; Fleury H
Am J Gastroenterol; 2000 Jul; 95(7):1765-9. PubMed ID: 10925982
[TBL] [Abstract][Full Text] [Related]
10. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F
Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India.
Chattopadhyay S; Rao S; Das BC; Singh NP; Kar P
Hemodial Int; 2005 Oct; 9(4):362-6. PubMed ID: 16219056
[TBL] [Abstract][Full Text] [Related]
13. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Watanabe H; Shinzawa H; Shao L; Saito T; Takahashi T
J Med Virol; 1999 Jul; 58(3):235-8. PubMed ID: 10447418
[TBL] [Abstract][Full Text] [Related]
14. [The prevalence of TTV infection in non-A to G chronic liver disease, especially non-A to G hepatocellular carcinoma, and the clinical significance of TTV infection].
Shibayama T; Igari T; Tsuda F
Nihon Rinsho; 1999 Jun; 57(6):1356-61. PubMed ID: 10390998
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of TT virus infection in patients with chronic hepatitis C.
Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of TT virus infection in Italian dialysis patients.
Rivanera D; Lozzi MA; Idili C; Lilli D
Pathol Biol (Paris); 2009 Feb; 57(1):97-100. PubMed ID: 18842354
[TBL] [Abstract][Full Text] [Related]
20. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
